|Day Low/High||307.47 / 313.37|
|52 Wk Low/High||220.05 / 345.15|
Bio-Rad Laboratories' CEO Discusses Q3 2011 Results - Earnings Call Transcript
HCA Holdings, Thermo Fisher and Covidien are defensive bets to beat market volatility, according to analysts.
Regulatory News: BioAlliance Pharma SA (Euronext Paris - BIO), a company dedicated to specialty and orphan oncology products, today announces: Following PAR Strativa restructuring and...
These defensive stocks have outperformed their peers and show potential upside.
Bio-Rad Laboratories' CEO Discusses Q2 2011 Results - Earnings Call Transcript
Bio-Rad Laboratories (NYSE:BIO) hit a new 52-week high Friday as it is currently trading at $126.15, above its previous 52-week high of $125.43 with 67,867 shares traded as of 12:11 p.m. ET. Average volume has been 70,000 shares over the past 30 days.
HCA coverage started at several firms with buy and outperform ratings. Cabot downgraded at Stifel from Buy to Hold. Eaton upgraded at Oppenheimer.
Bio-Rad Laboratories (NYSE:BIO) hit a new 52-week high Monday as it is currently trading at $125.22, above its previous 52-week high of $125.01 with 61,047 shares traded as of 2:36 p.m. ET. Average volume has been 69,300 shares over the past 30 days.
Google estimates, target raised at Morgan Stanley. Shares of GOOG now seen reaching $730.
QLogic downgraded at Morgan Stanley from Overweight to Equal-weight. Company is facing lower server demand.
Gregg Greenberg breaks down today's market action with guests Catherine Zhang, CFO of AutoNavi, and Jason Kelly, author of "Financially Stupid People Are Everywhere".
ManTech, FTI Consulting, Amdisys, Neogen and Bio-Rad make the list.
These 10 heavily shorted stocks could surge on any positive catalyst.
The CBOE Put/Call Ratio points to an upward market direction, so portion cash appropriately.
Steer clear of stocks being demoted in the next Russell index rebalancing.
Meanwhile, restaurant shares rebound and more beef-testing and alternative food stocks surge.
Shares of Bio-Rad Laboratories, Orchid BioSciences and V.I. Technologies surge.
Investors focus on mixed economic reports and mad cow disease in a holiday-shortened session.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.